Modella AI, a leader in artificial intelligence for life sciences, announced that it has been acquired by AstraZeneca, expanding the companies’ existing collaboration to...
Converge Bio, the AI platform for accelerated drug discovery and development, announced $25 million in Series A funding, bringing its total raised to $30...
In a historic agreement that symbolizes the increasingly rapid convergence between artificial intelligence and biotech, NVIDIA Corporation and Eli Lilly & Company announced the...
Kipu Health, a leading technology platform for the behavioral healthcare industry, has launched Kipu Helix, the first intelligent operating system specifically designed to help...
Multiply Labs, a front runner in the area of robotic biomanufacturing systems, has just made an announcement about a strategic partnership with NVIDIA to...
insitro, the AI therapeutics company built on causal biology, announced that it has entered into a definitive agreement to acquire CombinAbleAI and launch its...
Anthropic announced a major expansion to its Claude platform, adding Claude for Healthcare to its existing expanded capabilities in Claude for Life Sciences. These...
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
Revvity, Inc. announced a collaboration with Eli Lilly and Company (Lilly) that...
Here is AITech365’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the nuances...